Back to Trades
Ceesay Abraham
InsiderCIK 0001722140
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 15
- Buy transactions
- 0
- Sell transactions
- 42
- Companies
- 3
- Active
- 2025–2026
Ceesay Abraham has filed 15 SEC reports (2025–2026), spread across 3 companies, totaling $8.4M in disclosed volume. Weighing $0 bought versus $8.1M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
15 loaded
| Sep 24 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham | Insider | Sell | $86.6K |
| Sep 9 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham | Insider | Sell | $374.5K |
| Aug 26 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham | Insider | Sell | $938.0K |
| Aug 12 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham | Insider | Sell | $2.4M |
| Jul 29 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham | Insider | Sell | $93.1K |
| Jul 15 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham | Insider | Sell | $328.4K |
| Jul 1 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham | Insider | Sell | $327.4K |
| May 11 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Ceesay Abraham | Director | Grant | $255.4K |
| Feb 19 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham | Insider | Sell | $320.4K |
| Jan 22 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham | Insider | Sell | $285.1K |
| Dec 18 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham | Insider | Sell | $323.5K |
| Nov 18 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham | Insider | Sell | $275.0K |
| Oct 16 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham | Insider | Sell | $281.7K |
| Sep 19 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham | Insider | Sell | $2.0M |
| Sep 8 | PCRX Pacira BioSciences, Inc. | Ceesay Abraham | Director | Sell | $64.0K |
15 filings